RE: Science Day Recording26 Feb 2023 17:35
mowzer, my opinion of AS is my opinion based on whats gone before, I accept you don't agree with it.
I would make the point that people are people irrespective of the position they hold or have climbed their way to. Just because he is a scientist I don't elevate him personally onto a pedestal. He is as flawed as the rest of us.
(I know an internationally renowned, ground breaking surgeon for instance who you would not employ for his bedside manor as he sees the patient as a body, simply as away of further developing and advancing the area of research he has pioneered, but by god, you would want him to be holding the scapel. I digress.)
Given the 2 years of LFT research development, tests, RNS's and interviews as though it was a few knee jerk, off the cuff remarks is imo, rewriting history.
My bias here that puts me at odds with most is I understand I don't understand what they are doing at a technical level. (obviously I get the broad brush of it through AS's explanations), but as its never been done before and whenever anybody and I mean anybody here, starts explaining what's happening somebody will disagree and there will be a convoluted exchange, which is fine, but they both can't be right, and I don't know which one it is.
If you truly believe that it was all there in the RNS then great, I would also ask rhetorically if you like, did you believe everything that AS said about the LFT development and now with the aid of hindsight are there areas where you think he either deliberately misled or inadvertently misled?
If it can happen once can it happen again? That was my cautious approach on what seemed to me, obviously not to you, ambiguous remarks on a scripted interview.
]
Thats where I come from, that my bias, its caution first, and the basic questions are: will this investment increase in value and when is that likely? I can't know the answer to either, so I have to use experience and judgment to put a value on those 2 questions.
AVCT's past track record is not great: great trial, great test, no commercialisation. Will this be different? CEO very bullish (as before) results so far, exquisite (as before).
However,So far so very good, I am just more cautious than some here. To me its just another stock to hold that either will or won't come good. I use all the info I have to determine that incl. looking at the BoD's remarks, body language and tone.
We both still hold so whats the diff? we will arrive at the same destination, one way or the other.